Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Source: ventdusud | Shutterstock.com We’re taking a look at the biggest pre-market stock movers for Thursday that investors need to know about! Moving stocks this morning is clinical trial data, plans for a stock split, and more. Let’s get into that news below! Pre-Market Stock Movers: 10 Top Gainers Allena Pharmaceuticals (NASDAQ: ALNA ) stock is rocketing more than 39% after announcing the rescheduling of a meeting to vote on a reverse stock split. United Maritime (NASDAQ: USEA ) shares are gaining over 32% following its public debut after a spinoff . AcelRx Pharmaceuticals (NASDAQ: ACRX ) stock is soaring more than 25% alongside heavy trading of the shares. Leafly Holdings (NASDAQ: LFLY ) shares are surging over 17% despite a lack of news this morning. Cryptyde (NASDAQ: TYDE ) stock is increasing more than 16% roughly one week after its public debut . Dave (NASDAQ: DAVE ) shares are rising about 16% in pre-market trading Thursday. Veru (NASDAQ: VERU ) stock is climbing over 12% as it continues to rally on a clinical trial udpate .
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Source: ventdusud | Shutterstock.com We’re taking a look at the biggest pre-market stock movers for Thursday that investors need to know about! Moving stocks this morning is clinical trial data, plans for a stock split, and more. Let’s get into that news below! Pre-Market Stock Movers: 10 Top Gainers Allena Pharmaceuticals (NASDAQ: ALNA ) stock is rocketing more than 39% after announcing the rescheduling of a meeting to vote on a reverse stock split. United Maritime (NASDAQ: USEA ) shares are gaining over 32% following its public debut after a spinoff . AcelRx Pharmaceuticals (NASDAQ: ACRX ) stock is soaring more than 25% alongside heavy trading of the shares. Leafly Holdings (NASDAQ: LFLY ) shares are surging over 17% despite a lack of news this morning. Cryptyde (NASDAQ: TYDE ) stock is increasing more than 16% roughly one week after its public debut . Dave (NASDAQ: DAVE ) shares are rising about 16% in pre-market trading Thursday. Veru (NASDAQ: VERU ) stock is climbing over 12% as it continues to rally on a clinical trial udpate .